Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Sandoz Invests in New Biosimilar Manufacturing Facility

Big Molecule Watch · July 27, 2023

Janssen Seeks a Preliminary Injunction in BPCIA Ustekinumab Case Against Amgen

Big Molecule Watch · March 8, 2023

Denosumab Clinical Trial Updates

Big Molecule Watch · August 9, 2022

Mylan Voluntarily Recalls Additional Batch of Biosimilar Insulin Glargine Pens Due to Potential Missing Labels

Big Molecule Watch · July 8, 2022

Outlook Therapeutics to Revise Ophthalmic Bevacizumab BLA in Light of FDA Request

Big Molecule Watch · May 31, 2022